Model
Edge
Alnylam Pharmaceuticals, Inc.
0001886431
Filing Type
4
Filing Date
3/3/2026
Updated
3/4/26, 5:30 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership